生长分化因子15：调节脂肪组织能量代谢的新激素

doi:10.16138/j.1673-6087.2021.06.014

内科理论与实践 ›› 2021, Vol. 16 ›› Issue (06): 435-437.doi: 10.16138/j.1673-6087.2021.06.014

生长分化因子15：调节脂肪组织能量代谢的新激素

袁力, 韦晓, 陈国芳(), 刘超()

南京中医药大学附属中西医结合医院内分泌科江苏省中医药研究院国家中医药管理局瘿病证治国家重点研究室,江苏南京 210028

收稿日期:2021-03-26 出版日期:2021-12-27 发布日期:2022-07-25
通讯作者: 陈国芳,刘超 E-mail:chenguofang9801@126.com;liuchao@nfmcn.com
基金资助:
国家自然科学基金项目(81800756)

Received:2021-03-26 Online:2021-12-27 Published:2022-07-25

摘要/Abstract

关键词: 生长分化因子15, 脂肪组织, 脂肪分解, 产热, 白色脂肪棕色化

中图分类号:

R589.2

袁力, 韦晓, 陈国芳, 刘超. 生长分化因子15：调节脂肪组织能量代谢的新激素[J]. 内科理论与实践, 2021, 16(06): 435-437.

参考文献 25

[1]	Malik VS, Willet WC, Hu FB. Nearly a decade on - trends, risk factors and policy implications in global obesity[J]. Nat Rev Endocrinol, 2020, 16(11): 615-616. doi: 10.1038/s41574-020-00411-y URL
[2]	Ng R, Sutradhar R, Yao Z, et al. Smoking, drinking, diet and physical activity-modifiable lifestyle risk factors and their associations with age to first chronic disease[J]. Int J Epidemiol, 2020, 49(1): 113-130. doi: 10.1093/ije/dyz078 URL
[3]	Kwok S, Adam S, Ho JH, et al. Obesity: a critical risk factor in the COVID-19 pandemic[J]. Clin Obes, 2020, 10(6): e12403.
[4]	Breit SN, Brown DA, Tsai VW. The GDF15-GFRAL pathway in health and metabolic disease: friend or foe?[J]. Annu Rev Physiol, 2021, 83: 127-151. doi: 10.1146/annurev-physiol-022020-045449 URL
[5]	Tsai VW, Zhang HP, Manandhar R, et al. GDF 15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS[J]. Int J Obes (Lond), 2019, 43(12): 2370-2380. doi: 10.1038/s41366-019-0365-5 URL
[6]	Tsai VWW, Husaini Y, Sainsbury A, et al. The MIC-1/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases[J]. Cell Metab, 2018, 28(3): 353-368. doi: 10.1016/j.cmet.2018.07.018 URL
[7]	Hsu JY, Crawley S, Chen M, et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15[J]. Nature, 2017, 550(7675): 255-259. doi: 10.1038/nature24042 URL
[8]	Adela R, Banerjee SK. GDF-15 as a target and biomarker for diabetes and cardiovascular diseases[J]. J Diabetes Res, 2015, 2015: 490842.
[9]	Lockhart SM, Saudek V, O’Rahilly S. GDF15: a hormone conveying somatic distress to the brain[J]. Endocr Rev, 2020, 41(4): 610-642.
[10]	Chrysovergis K, Wang X, Kosak J, et al. NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism[J]. Int J Obes (Lond), 2014, 38(12): 1555-1564. doi: 10.1038/ijo.2014.27 URL
[11]	Chung HK, Ryu D, Kim KS, et al. Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis[J]. J Cell Biol, 2017, 216(1): 149-165. doi: 10.1083/jcb.201607110 pmid: 27986797
[12]	Emmerson PJ, Wang F, Du Y, et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL[J]. Nat Med. 2017, 23(10): 1215-1219. doi: 10.1038/nm.4393 pmid: 28846098
[13]	Laurens C, Parmar A, Murphy E, et al. Growth and differentiation factor 15 is secreted by skeletal muscle during exercise and promotes lipolysis in humans[J]. JCI Insight, 2020, 5(6): e131870. doi: 10.1172/jci.insight.131870 URL
[14]	Tsai VW, Zhang HP, Manandhar R, et al. Treatment with the TGF-b superfamily cytokine MIC-1/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity[J]. Int J Obes (Lond), 2018, 42(3): 561-571. doi: 10.1038/ijo.2017.258 URL
[15]	Cannon B, Nedergaard J. Nonshivering thermogenesis and its adequate measurement in metabolic studies[J]. J Exp Biol, 2011, 214 Pt 2: 242-253.
[16]	Campderrós L, Moure R, Cairó M, et al. Brown adipocytes secrete GDF15 in response to thermogenic activation[J]. Obesity (Silver Spring), 2019, 27(10): 1606-1616. doi: 10.1002/oby.22584 URL
[17]	Quesada-López T, Cereijo R, Turatsinze JV, et al. The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes[J]. Nat Commun, 2016, 7: 13479. doi: 10.1038/ncomms13479 pmid: 27853148
[18]	Flicker D, Sancak Y, Mick E, et al. Exploring the in vivo role of the mitochondrial calcium uniporter in brown fat bioenergetics[J]. Cell Rep, 2019, 27(5): 1364-1375. doi: S2211-1247(19)30468-1 pmid: 31042465
[19]	Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential[J]. Nat Med, 2013, 19(10): 1252-1263. doi: 10.1038/nm.3361 URL
[20]	Bargut TCL, Souza-Mello V, Aguila MB, et al. Browning of white adipose tissue: lessons from experimental models[J]. Horm Mol Biol Clin Investig, 2017, 31(1): 20160051.
[21]	Ost M, Igual Gil C, Coleman V, et al. Muscle-derived GDF15 drives diurnal anorexia and systemic metabolic remodeling during mitochondrial stress[J]. EMBO Rep, 2020, 21(3): e48804.
[22]	Geurts L, Everard A, Van Hul M, et al. Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota[J]. Nat Commun, 2015, 6: 6495. doi: 10.1038/ncomms7495 pmid: 25757720
[23]	Tindle HA, Omalu B, Courcoulas A, et al. Risk of suicide after long-term follow-up from bariatric surgery[J]. Am J Med, 2010, 123(11): 1036-1042. doi: 10.1016/j.amjmed.2010.06.016 URL
[24]	Lee P, Smith S, Linderman J, et al. Temperature-acclimated brown adipose tissue modulates insulin sensitivity in humans[J]. Diabetes, 2014, 63(11): 3686-3698. doi: 10.2337/db14-0513 URL
[25]	Oka M, Kobayashi N, Matsumura K, et al. New role for growth/differentiation factor 15 in the survival of transplanted brown adipose tissues in cooperation with interleukin-6[J]. Cells, 2020, 9(6): 1365. doi: 10.3390/cells9061365 URL

生长分化因子15：调节脂肪组织能量代谢的新激素

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 25

相关文章 15

编辑推荐

Metrics

本文评价

[1]	于子优蔡宜佐李伟张文杰. 无细胞脂肪组织提取液在皮肤及软组织再生修复中的应用[J]. 组织工程与重建外科杂志, 2021, 17(6): 561-.
[2]	吴昊, 白英, 邓可武. 心外膜脂肪组织与心血管疾病和代谢性疾病[J]. 内科理论与实践, 2021, 16(03): 208-211.
[3]	鲍婉婷, 曹丽辰, 魏昊, 余力, 周广东, 郭善禹. PGS构建特定形状脂肪组织的可行性研究[J]. 组织工程与重建外科杂志, 2020, 16(2): 87-90.
[4]	张郭, 周牧冉, 陈佳龙, 汪振星, 孙家明. 组织工程乳房的研究进展及临床展望[J]. 组织工程与重建外科杂志, 2020, 16(2): 160-164.
[5]	周鑫昀, 陈惠, 沈立松. 新型血清纤维化标志物在IgG4相关性疾病诊断评价中的临床价值[J]. 诊断学理论与实践, 2019, 18(03): 329-333.
[6]	王运东, 张运东, 王立志,. 血清生长分化因子15水平对慢性肝病患者严重程度的评估价值及其临床意义[J]. 内科理论与实践, 2019, 14(03): 183-187.
[7]	张佩祺，周双白，李青峰. 脂肪组织长期储存的研究进展[J]. 组织工程与重建外科杂志, 2018, 14(5): 295-297.
[8]	何际洲，高博闻，程辰，李青峰. 脂肪组织的分类及研究进展[J]. 组织工程与重建外科杂志, 2017, 13(4): 224-227.
[9]	李俊伟, 夏寒冰, 赵红丽, 刘淑霞. 基于超声测量的心外膜脂肪组织厚度预测冠心病的价值[J]. 诊断学理论与实践, 2017, 16(03): 324-327.
[10]	桂燕萍, 施仲伟,. 超声测量心外膜脂肪组织厚度在慢性心力衰竭患者中的临床价值[J]. 诊断学理论与实践, 2016, 15(03): 248-252.
[11]	齐笑, 简蔚霞,. 脂肪组织对骨代谢的调节关系[J]. 内科理论与实践, 2015, 10(06): 456-459.
[12]	丁金萍，孙恒赟，陈谨君，张文杰，刘伟，曹谊林，周广东. CD204阴性人脂肪来源细胞体外成软骨潜能的初步研究[J]. 组织工程与重建外科杂志, 2012, 8(1): 1-5.
[13]	李淼, 胡伟伟, 张增, 胡云秋, 章振林,. 410名绝经后健康妇女身体成分与骨密度相关性的研究[J]. 诊断学理论与实践, 2012, 11(01): 30-33.
[14]	熊永华, 姜云涛, 吴敏, 赖旭芝. 基于产热量优化的烧结余热回收操作参数设定[J]. 上海交通大学学报（自然版）, 2011, 45(08): 1119-1124.
[15]	曲伸, 刘蒙, 高鑫,. 胰岛素抵抗与非酒精性脂肪性肝病关系的认识[J]. 诊断学理论与实践, 2009, 8(03): 240-243.